Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma.

Maes W, Rosas GG, Verbinnen B, Boon L, De Vleeschouwer S, Ceuppens JL, Van Gool SW.

Neuro Oncol. 2009 Oct;11(5):529-42. doi: 10.1215/15228517-2009-004. Epub 2009 Mar 31.

2.

Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells.

Rech AJ, Vonderheide RH.

Ann N Y Acad Sci. 2009 Sep;1174:99-106. doi: 10.1111/j.1749-6632.2009.04939.x. Review.

PMID:
19769742
3.

In situ dendritic cell vaccination for the treatment of glioma and literature review.

Li M, Han S, Shi X.

Tumour Biol. 2016 Feb;37(2):1797-801. doi: 10.1007/s13277-015-3958-1. Epub 2015 Aug 29. Review.

PMID:
26318301
4.

Potential approaches for more successful dendritic cell-based immunotherapy.

Chiang CL, Balint K, Coukos G, Kandalaft LE.

Expert Opin Biol Ther. 2015 Apr;15(4):569-82. doi: 10.1517/14712598.2015.1000298. Epub 2015 Jan 2. Review.

PMID:
25553913
5.

Immunotherapy for malignant gliomas.

Bloch O.

Cancer Treat Res. 2015;163:143-58. doi: 10.1007/978-3-319-12048-5_9. Review.

PMID:
25468230
6.

Basic concepts in glioma immunology.

Parney IF.

Adv Exp Med Biol. 2012;746:42-52. doi: 10.1007/978-1-4614-3146-6_4. Review.

PMID:
22639158
7.

Peptide vaccine.

Izumoto S.

Adv Exp Med Biol. 2012;746:166-77. doi: 10.1007/978-1-4614-3146-6_13. Review.

PMID:
22639167
8.

Cellular immunotherapy for malignant gliomas.

Lin Y, Okada H.

Expert Opin Biol Ther. 2016 Oct;16(10):1265-75. doi: 10.1080/14712598.2016.1214266. Epub 2016 Jul 29. Review.

9.

Dendritic cell-based vaccine for the treatment of malignant glioma: a systematic review.

Wang X, Zhao HY, Zhang FC, Sun Y, Xiong ZY, Jiang XB.

Cancer Invest. 2014 Nov;32(9):451-7. doi: 10.3109/07357907.2014.958234. Epub 2014 Sep 26. Review.

PMID:
25259676
10.

Dendritic cell vaccines.

Yamanaka R, Kajiwara K.

Adv Exp Med Biol. 2012;746:187-200. doi: 10.1007/978-1-4614-3146-6_15. Review.

PMID:
22639169
11.

[Immunotherapy in brain tumors].

De Carli E, Delion M, Rousseau A.

Ann Pathol. 2017 Feb;37(1):117-126. doi: 10.1016/j.annpat.2016.12.001. Epub 2017 Jan 19. Review. French.

PMID:
28111040
12.

Glioma antigen.

Toda M.

Adv Exp Med Biol. 2012;746:77-84. doi: 10.1007/978-1-4614-3146-6_6. Review.

PMID:
22639160
13.

Dendritic cell immunotherapy for malignant gliomas.

Luptrawan A, Liu G, Yu JS.

Rev Recent Clin Trials. 2008 Jan;3(1):10-21. Review.

PMID:
18474011
14.

Brain tumor immunotherapy with type-1 polarizing strategies.

Okada H.

Ann N Y Acad Sci. 2009 Sep;1174:18-23. doi: 10.1111/j.1749-6632.2009.04932.x. Review.

PMID:
19769732
15.

Altering regulatory T cell function in cancer immunotherapy: a novel means to boost the efficacy of cancer vaccines.

Ruter J, Barnett BG, Kryczek I, Brumlik MJ, Daniel BJ, Coukos G, Zou W, Curiel TJ.

Front Biosci (Landmark Ed). 2009 Jan 1;14:1761-70. Review.

PMID:
19273160
16.

Dendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trials.

Mineharu Y, Castro MG, Lowenstein PR, Sakai N, Miyamoto S.

Neurol Med Chir (Tokyo). 2013;53(11):741-54. Epub 2013 Oct 21. Review.

17.

Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy.

Anguille S, Lion E, Van den Bergh J, Van Acker HH, Willemen Y, Smits EL, Van Tendeloo VF, Berneman ZN.

Hum Vaccin Immunother. 2013 Sep;9(9):1956-61. doi: 10.4161/hv.25373. Epub 2013 Jun 18. Review.

18.

The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.

Maxwell R, Luksik AS, Garzon-Muvdi T, Lim M.

Curr Neurol Neurosci Rep. 2017 Jun;17(6):50. doi: 10.1007/s11910-017-0754-x. Review.

PMID:
28488122
19.

Dendritic cell based vaccination strategy: an evolving paradigm.

Filley AC, Dey M.

J Neurooncol. 2017 Jun;133(2):223-235. doi: 10.1007/s11060-017-2446-4. Epub 2017 Apr 22. Review.

PMID:
28434112
20.

Dendritic/tumor fusion cells as cancer vaccines.

Avigan D, Rosenblatt J, Kufe D.

Semin Oncol. 2012 Jun;39(3):287-95. doi: 10.1053/j.seminoncol.2012.02.003. Review.

PMID:
22595051

Supplemental Content

Support Center